Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
International Journal of Clinical Pharmacy|March 3, 2011
From evidence based medicine to mechanism based medicine. Reviewing the role of pharmacogeneticsBob Wilffert, Jesse Swen, Hans Mulder, et al.
Plos One|August 22, 2018
Monitoring of somatic parameters at outpatient departments for mood and anxiety disordersMirjam Simoons, Hans Mulder, Bennard Doornbos, et al.
International Journal of Clinical Pharmacy|November 5, 2010
From evidence based medicine to mechanism based medicine. Reviewing the role of pharmacogeneticsBob Wilffert, Jesse Swen, Hans Mulder, et al.
The Annals of Pharmacotherapy|March 8, 2007
Prevalence of patients using drugs metabolized by cytochrome P450 2D6 in different populations: a cross-sectional studyHans Mulder, Eibert R Heerdink, Elsje E van Iersel, et al.
Pharmacoepidemiology and Drug Safety|November 19, 2005
The impact of cytochrome P450-2D6 genotype on the use and interpretation of therapeutic drug monitoring in long-stay patients treated with antidepressant and antipsychotic drugs in daily psychiatric practiceHans Mulder, Anita Herder, Frederik W Wilmink, et al.
BMC Psychiatry|April 13, 2021
Applicability of somatic monitoring instructions in clinical practice guidelines on antipsychotic drug useJurriaan M J L Brouwer, Erien Olde Hengel, Arne J Risselada, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 19, 2020
[Discontinuation of SSRIs and SNRIs]Henricus G Ruhe, Annemieke Horikx, Mariëlle J P van Avendonk, et al.
Journal of Affective Disorders|March 17, 2024
High persistence and low treatment rates of metabolic syndrome in patients with mood and anxiety disorders: A naturalistic follow-up studyJurriaan M J L Brouwer, Klaas J Wardenaar, Edith J Liemburg, et al.
International Journal of Clinical Pharmacy|July 13, 2022
Lithium surveillance by community pharmacists and physicians in ambulatory patients: a retrospective cohort studyJurriaan M J L Brouwer, Arne J Risselada, Marinka de Wit, et al.
The Journal of Clinical Psychiatry|January 12, 2017
Medication Discrepancies at Outpatient Departments for Mood and Anxiety Disorders in the Netherlands: Risks and Clinical RelevanceMirjam Simoons, Hans Mulder, Arne J Risselada, et al.
Pageof 5